Question : LOAN BY CSIR

(a) CSIR is providing soft loans for R&D under various schemes; and

(b) if so, the details of various schemes and the loans advanced during each of the last three years?

MINISTER OF STATE(INDEPENDENT CHARGE) OF THE MINISTRY OF SCIENCE AND TECHNOLOGY AND MINISTER OF STATE(INDEPENDENT CHARGE) OF THE DEPARTMENT OF OCEAN DEVELOPMENT(KAPIL SIBAL)

(a) Yes Sir.

(b) CSIR is implementing a national scheme entitled New Millennium Indian Technology Leadership Initiative (NMITLI). The objective of the NMITLI is to catalyze innovation centered scientific and technological developments as a vehicle to attain for Indian industry a global leadership position, in selected niche areas in a true ‘Team India’ spirit, by synergising the best competencies of publicly funded R&D institutions, academia and private industry. The scheme is the largest public-private-partnership R&D effort in the country in which the Government plays a catalytic role. It is based on the premise of consciously and deliberately identifying, selecting and supporting potential winners. Under the scheme, a provision exists for providing soft loans @3% interest to Indian industrial partners for undertaking specific components of the work in the identified projects. The loan advanced to industry up to March 31, 2005 is given at annexure-I.

Annexure-I

Loan advanced to Indian Industry under NMITLI

(Rs. in Lakh)
Project Name	Party Name	2002-03	2003-04	2004-05
5 & 25kw decentralized power packs	Sud-Chemie India Ltd., New Delhi	40.00	-	10.00
Latent M. Tuberculosis: New Targets,	Lupin Ltd.	-	500.00	375.00
Drug Delivery system, bio-enhancers
and therapeutics
Nano-material catalysts & assocated	Sud-Chemie India Ltd., New Delhi	85.00	10.00	-
process technology for alkylation/
acylation reaction, pre-reforming of
hydro-carbons and sulpur removal 

(
Development of versatile, portable	TCS, Hyderabad	390.000	174.00	-
software for bioinformatics	Jalaja Technologis Pvt. Ltd.,	12.000	-	-	Bangl’re	FTIL, Secund’bad	20.000	-	-
Development of an oral herbal	Lupin Ltd., Mumbai	281.40	352.56	-
formulation for treatment of
Psoriasis: a clinical and
scientific challenge
Development of novel biotech	Bharat Biotech International	410.00	150.62	-
moleular lysostaphin	Ltd., Hyderabad
Microbiological conversion of	Alembic Ltd., Vadodara	23.50	5.00
Erythromycin to clarithromycin and
other novel biologically active
molecules
Novel molecular diagnostics for eye	Lensel Optics Pvt. Ltd., Pune	5.15	9.60	-
diseases and low vision enhancement
devices
Recombinant approach to produce	Avastha Gengraine Technology	130.5	90.60	44.90
alpha-linolenic acid and	Pvt.Ltd.,Bangalore
docosahexanoic acid (DHA) in
sunflower and yeast
A cost effective simple office	Encore Software Ltd., Bangalore	200.00	120.000	-
computer (Sofcomp) platform to
replace PC
A PC based high-end 3D visualisation	Strand Gennomics Pvt. Ltd., Bangalore	106.40	80.00	-
platform for computational
biology- “Darshee”
Improved annotation of Plasmodium	TCS, Hyderabd	-	97.00	-
falciparam through combination of
machine learning and experimental
methods: Annotation and experimental
validation of specific pathways
Total	1703.95	1589.38	429.90